EUVIMEDScopri EUVIMED
KohortenstudieStudienprotokollOpen access

Pharmacist-Led Continuous Glucose Monitoring for Prediabetes: Protocol for a Prospective Cohort Study

Kevin Cowart iD, Raechel T White iD, Nicholas W Carris iD, Benedicta O Ansong iD, Alyssa Hinden iD, Gwendolyn Clayton iD, John Petrilli iD, Eric Coris iD

JMIR Research Protocols · 2026

DOI: 10.2196/105275 ↗

At a glance

Kohortenstudie in JMIR Research Protocols, 2026. Written by Kevin Cowart and 7 co-authors. Institution: Department of Pharmacotherapeutics & Clinical Research, University of South Florida Taneja College of Pharmacy, Tampa, FL, United States. Major MEDLINE topics: Continuous Glucose Monitoring, Pharmacists, Prediabetic State. 36 references. The full text is freely available in PubMed Central.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Background

Prediabetes represents a critical intervention window to reduce progression to type 2 diabetes. The current standard of care for treatment of prediabetes is weight loss and lifestyle modification, which are both highly effective, although limited by real-world adherence. It is well recognized that continuous glucose monitoring (CGM) improves glycemic and behavioral outcomes in people with diabetes, although outcomes among people with prediabetes are not well described.

Objective

The aim of this study is to evaluate the impact of pharmacist-led CGM on glycemic control and health-related behaviors in adults with prediabetes.

Methods

This study includes a prospective pharmacist-led CGM cohort and a matched retrospective usual-care cohort. Adults aged 18 to 70 years with prediabetes (hemoglobin A1c [HbA1c] 5.7%-6.4%) will be eligible for the prospective cohort if they have a compatible smartphone and no CGM use in the prior 6 months. Participants will receive CGM (Stelo glucose biosensor; Dexcom) and diabetes self-management education and support over 12 weeks. The primary outcome is the change in HbA1c at 12 weeks, compared between groups. Secondary outcomes include CGM-derived metrics, changes in Summary of Diabetes Self-Care Activities scores and 36-Item Short Form Health Survey scores, and CGM-related adverse effects.

Results

This study was funded in 2026. Recruitment is ongoing, and no participants had been enrolled at the time of writing. The planned sample size is 40 participants: 20 prospective CGM participants and 20 retrospective controls. Outcome data are not yet available. The study is expected to be completed in July 2027, and the results are anticipated to be disseminated in December 2027.

Conclusions

This study seeks to evaluate the glycemic impact, behavior change, and safety of pharmacist-led CGM for prediabetes in primary care. Trial Registration ClinicalTrials.gov NCT07529366; https://tinyurl.com/33bv7u8c International Registered Report Identifier (IRRID) PRR1-10.2196/105275

Subjects

MeSH terms (MEDLINE)

Continuous Glucose MonitoringPharmacistsPrediabetic StateAdolescentAdultAgedFemaleHumansMaleMiddle AgedYoung AdultBlood GlucoseDiabetes Mellitus, Type 2Glycated HemoglobinProspective StudiesObservational Studies as Topic

Author keywords

continuous glucose monitoringdiabetes preventionhealth behaviorpharmacistprediabetesprimary care

Substances

Blood GlucoseGlycated Hemoglobin

Authors and institutions

  • Department of Pharmacotherapeutics & Clinical Research, University of South Florida Taneja College of Pharmacy, Tampa, FL, United States.
  • Department of Family Medicine, University of South Florida Morsani College of Medicine, Tampa, FL, United States.
  • University of South Florida College of Public Health, Tampa, FL, United States.

ORCID profiles: Kevin Cowart, Raechel T White, Nicholas W Carris, Benedicta O Ansong, Alyssa Hinden, Gwendolyn Clayton, John Petrilli, Eric Coris

Cite

APA

Cowart, K., White, R. T., Carris, N. W., Ansong, B. O., Hinden, A., Clayton, G., Petrilli, J., & Coris, E. (2026). Pharmacist-Led Continuous Glucose Monitoring for Prediabetes: Protocol for a Prospective Cohort Study. JMIR Research Protocols. https://doi.org/10.2196/105275

Vancouver

Cowart K, White RT, Carris NW, Ansong BO, Hinden A, Clayton G, et al. Pharmacist-Led Continuous Glucose Monitoring for Prediabetes: Protocol for a Prospective Cohort Study. JMIR Research Protocols. 2026. doi:10.2196/105275

BibTeX
@article{Cowart2026,
  author = {Cowart, Kevin and White, Raechel T and Carris, Nicholas W and Ansong, Benedicta O and Hinden, Alyssa and Clayton, Gwendolyn and Petrilli, John and Coris, Eric},
  title = {Pharmacist-Led Continuous Glucose Monitoring for Prediabetes: Protocol for a Prospective Cohort Study},
  journal = {JMIR Research Protocols},
  year = {2026},
  doi = {10.2196/105275}
}
Start for free →